Fungal infection in hemato-oncologic patients: better to prevent than to treat?

被引：2

作者：

van t'Wout, JW ^{[1
]}

van Dissel, JT ^{[1
]}

机构：

[1] Leiden Univ, Med Ctr, NL-2300 RA Leiden, Netherlands

来源：

BLOOD | 2004年 / 103卷 / 04期

关键词：

D O I：

10.1182/blood-2003-12-4112

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1182 / 1183

页数：2

共 5 条

[1]

ECKER MJ, 2003, BRIT J HAEMATOL, V121, P448

[2] Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis [J].

Herbrecht, R ;

Denning, DW ;

Patterson, TF ;

Bennett, JE ;

Greene, RE ;

Oestmann, JW ;

Kern, WV ;

Marr, KA ;

Ribaud, P ;

Lortholary, O ;

Sylvester, R ;

Rubin, RH ;

Wingard, JR ;

Stark, P ;

Durand, C ;

Caillot, D ;

Thiel, E ;

Chandrasekar, PH ;

Hodges, MR ;

Schlamm, HT ;

Troke, PF ;

de Pauw, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :408-415

[3] Prophylaxis, empirical therapy, or pre-emptive therapy of fungal infections in immunocompromised patients: which is better for whom? [J].

Leather, HL ;

Wingard, JR .

CURRENT OPINION IN INFECTIOUS DISEASES, 2002, 15 (04) :369-375

[4] Invasive fungal infections in hematology:: new trends [J].

Martino, R ;

Subirà, M .

ANNALS OF HEMATOLOGY, 2002, 81 (05) :233-243

[5] Multidrug resistance in Aspergillus fumigatus. [J].

Warris, A ;

Weemaes, CM ;

Verweij, PE .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (26) :2173-2174

← 1 →